Literature DB >> 31764246

How Soon Should Patients With Colon Cancer Undergo Definitive Resection?

Robert J Kucejko1, Timothy J Holleran1, David E Stein2, Juan L Poggio2.   

Abstract

BACKGROUND: Timing of surgery has been shown to affect outcomes in many forms of cancer, but definitive national data do not exist to determine the effect of time to surgery on survival in colon cancer.
OBJECTIVE: This study aimed to determine whether a delay in definitive surgery in colon cancer significantly affects survival. DATA SOURCES: A retrospective cohort study using 2 independent population-based databases, The Surveillance, Epidemiology, and End Results Medicare-linked database and the National Cancer Database, was performed. STUDY SELECTION: All patients had American Joint Committee on Cancer stage 1 through 3 colon cancer. Patients were more than 18 years of age in the National Cancer Database cohort and older than 66 years of age in the Medicare cohort. Patients had a minimum of 3 years of follow-up. MAIN OUTCOME MEASURES: The main outcome was overall survival as a function of time between diagnosis and surgery in 4 intervals (1-2, 3-4, 5-6, >6 weeks).
RESULTS: The Medicare cohort demonstrated an adjusted 5-year survival of 8% to 14% higher in patients with a surgical delay between 3 and 6 weeks, with significantly lower hazard ratios in that interval. The National Cancer Database cohort demonstrated an adjusted 5-year survival of 9% to 16% higher in patients with surgery 3 to 6 weeks after diagnosis, with comparatively similar improvements in survival hazard. LIMITATIONS: Because this was a retrospective study of administrative databases, with Medicare data limited to billing data, the causality of outcomes must be interpreted with caution.
CONCLUSIONS: The ideal timing of definitive resection in colon cancer is between 3 and 6 weeks after initial diagnosis. All efforts should be made for patients to obtain definitive surgery within this interval to achieve a modest but significant improvement in overall survival. See Video Abstract at http://links.lww.com/DCR/B76. ¿CUÁNDO DEBEN SOMETERSE LOS PACIENTES CON CÁNCER DE COLON A UNA RESECCIÓN DEFINITIVA?: Se ha demostrado que el momento de la cirugía afecta los resultados en muchas formas de cáncer, pero no existen datos nacionales definitivos para determinar el efecto del tiempo hasta la cirugía en la supervivencia en el cáncer de colon.Determinar si un retraso en la cirugía definitiva en el cáncer de colon afecta significativamente la supervivencia.Un estudio de cohorte retrospectivo que utiliza dos bases de datos independientes basadas en la población; Se realizó la base de datos vinculada a la vigilancia, la epidemiología y los resultados finales y la base de datos nacional del cáncer.Pacientes con cáncer de colon en estadíos 1 a 3 del Comité Estadounidense Conjunto sobre el Cáncer. Los pacientes tenían más de 18 años en la cohorte de la National Cancer Database y más de 66 años en la cohorte de Medicare. Los pacientes tuvieron un mínimo de 3 años de seguimiento.El resultado principal fue la supervivencia general en función del tiempo entre el diagnóstico y la cirugía en 4 intervalos (1-2, 3-4, 5-6, y mas de 6 semanas).La cohorte de Medicare demostró una supervivencia ajustada de 5 años de 8 a 14% más en pacientes con un retraso quirúrgico entre 3 a 6 semanas, con razones de riesgo significativamente más bajas en ese intervalo. La cohorte de la National Cancer Database demostró una supervivencia ajustada a 5 años de 9 a 16% más en pacientes con cirugía de 3 a 6 semanas después del diagnóstico, con mejoras comparativamente similares en el riesgo de supervivencia.Dado que este fue un estudio retrospectivo de bases de datos administrativas, con datos de Medicare limitados a datos de facturación, la causalidad de los resultados debe interpretarse con precaución.El momento ideal para la resección definitiva en el cáncer de colon es entre tres y seis semanas después del diagnóstico inicial. Se deben hacer todos los esfuerzos para que los pacientes obtengan una cirugía definitiva dentro de este intervalo para lograr una mejora modesta pero significativa en la supervivencia general. Consulte Video Resumen en http://links.lww.com/DCR/B76.

Entities:  

Mesh:

Year:  2020        PMID: 31764246     DOI: 10.1097/DCR.0000000000001525

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

Review 1.  Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.

Authors:  Charlotte J L Molenaar; Loes Janssen; Donald L van der Peet; Desmond C Winter; Rudi M H Roumen; Gerrit D Slooter
Journal:  World J Surg       Date:  2021-04-03       Impact factor: 3.352

Review 2.  Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta-analysis.

Authors:  Thomas M Whittaker; Mohamed E G Abdelrazek; Aran J Fitzpatrick; Joseph L J Froud; Jack R Kelly; Jeremy S Williamson; Gethin L Williams
Journal:  Colorectal Dis       Date:  2021-03-25       Impact factor: 3.917

3.  Surgical Strategies in the Era of SARS-CoV-2.

Authors:  Dimitrios Dimitroulis; Nikolaos Garmpis; Christos Damaskos
Journal:  Pan Afr Med J       Date:  2020-04-27

4.  DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey.

Authors:  Giulio A Santoro; Ugo Grossi; Sthela Murad-Regadas; Joseph W Nunoo-Mensah; Anders Mellgren; Gian Luca Di Tanna; Gaetano Gallo; Charles Tsang; Steven D Wexner
Journal:  Surgery       Date:  2020-11-17       Impact factor: 3.982

5.  Evaluating the feasibility of performing elective gastrointestinal cancer surgery during the COVID-19 pandemic: An observational study with 60 days follow-up results of a tertiary referral pandemic hospital.

Authors:  Alper Sozutek; Ahmet Seker; Adnan Kuvvetli; Nazmi Ozer; Ismail Caner Genc
Journal:  J Surg Oncol       Date:  2021-02-09       Impact factor: 3.454

6.  Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.

Authors:  Monika Kozłowska-Geller; Stanisław Głuszek; Piotr Lewitowicz
Journal:  Prz Gastroenterol       Date:  2021-03-31

7.  Melbourne colorectal collaboration: a multicentre review of the impact of COVID-19 on colorectal cancer in Melbourne, Australia.

Authors:  Michelle Zhiyun Chen; Yeng Kwang Tay; Wiliam Mk Teoh; Joseph Ch Kong; Peter Carne; Basil D'Souza; Raaj Chandra; Andrew Bui
Journal:  ANZ J Surg       Date:  2022-04-08       Impact factor: 2.025

8.  Applying Latent Class Analysis on Cancer Registry Data to Identify and Compare Health Disparity Profiles in Colorectal Cancer Surgical Treatment Delay.

Authors:  Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Martin Whiteside; Hadii Mamudu; Faustine Williams
Journal:  J Public Health Manag Pract       Date:  2022 Mar-Apr 01

9.  Italian society of colorectal surgery recommendations for good clinical practice in colorectal surgery during the novel coronavirus pandemic.

Authors:  G Gallo; M La Torre; R Pietroletti; F Bianco; D F Altomare; S Pucciarelli; G Gagliardi; R Perinotti
Journal:  Tech Coloproctol       Date:  2020-04-14       Impact factor: 3.781

10.  Does delaying curative surgery for colorectal cancer influence long-term disease-free survival? A cohort study.

Authors:  Stephanie Garcia-Botello; J Martín-Arevalo; C Cozar-Lozano; A Benitez-Riesco; D Moro-Valdezate; V Pla-Martí; A Espí-Macías
Journal:  Langenbecks Arch Surg       Date:  2021-07-11       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.